Abstract

Drug development is both scientifically and economically driven. Past efforts to support the process have had great success, but increasing economic and regulatory pressures again threaten continued progress. The path from discovery to clinical use is in need of reevaluation with regard to substantive changes to reenergize the process. Such reevaluation includes clinical pharmacology input from all in our academia, industry, and regulatory sectors.

Original languageEnglish (US)
Pages (from-to)519-522
Number of pages4
JournalClinical pharmacology and therapeutics
Volume96
Issue number5
DOIs
StatePublished - Nov 1 2014

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'Drug development (and academic medicine): charting the course forward'. Together they form a unique fingerprint.

Cite this